MedTrace Logo

Conservative Surgery for Abnormally Invasive Placenta: A New Technique

NCT04193618 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-08-31

No results posted yet for this study

Summary

Placental borders and mapping by ultrasonography and Doppler ultrasonography (placental mapping) preop. And verified intraoperatively .

bladder peritoneal dissection till the level of internal Os Uterus is incised away from the placenta

\*Baby was delivered , the uterus is exteriorised and 4-5 towel clips are applied rapidly control uterine incision site bleeding .

Twenty units of diluted oxytocin and 100 to 200 cc, 37°C of heated saline were infused from here, and then the cord was clamped .

Then we proceed to systemically devascularize the uterus with the placenta in site

* internal iliac artery distal ligation:
* broad ligament and ureteric dissection:
* uterine vessels :
* posterior uterine wall compression suture :
* The utero-ovarian anastomosis branches are spared to keep blood flowing to the uterus.
* if the bladder was not fully dissected from the anterior uterine wall , now we complete the dissection,
* anterior uterine wall compression suture :
* now , we excise the invaded , irreparable anterior wall segment, with the
* then separation of the placenta manually
* if there's still mild bleeding from the uterine placental bed another full myometrial thickness anterior or posterior uterine wall transverse sutures are applied below or above the placental bed site to control bleeding until it's deemed acceptable
* in cases with separate fundal anterior incision, the high incision is repaired in layers first to give more time to compress and monitor the lower segment
* refashioning of the Lower segment , repair transversely is usually done,

Conditions

  • Placenta Accreta

Interventions

PROCEDURE

Conservative surgery for placenta accretta

Uterine devasculrization and transverse compressing sutures before placental delivery

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed maged · Professor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-12-11
Completion
2021-03-06

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04193618 on ClinicalTrials.gov